Therapeutic Development Learning Community Survey

[Christine Lagana Riordan]

Therapeutic Development Learning Community Survey

The purpose of the survey is to gather information on the level of engagement and interest that members have in the development of new therapeutics. This is a complex area and as many of us do not have a therapeutics development background the Therapeutic Development Learning Community team is planning to host a series of “What Does it Cost?” webinars in 2026, bringing in experts to open up the conversation. The input from the questionnaire will assist in the design of the series.

You can access the survey here: https://www.surveymonkey.com/r/L9V9QKW

Thank you for your participation!

Therapeutic Development Community Co-Chairs

• Maaike Everts, PhD, Executive Director, TRxA – the Translational Therapeutics Accelerator Program Critical Path Institute
• Mary O’Reilly, PhD, VP Bioscience Research, Flinn Foundation
• Kaitlin Davis, PhD, Director of Translational Science, Additional Ventures

[Christine Lagana Riordan]

REMINDER: Take the Therapeutic Development Learning Community Survey

The purpose of the survey is to gather information on the level of engagement and interest that members have in the development of new therapeutics. This is a complex area and as many of us do not have a therapeutics development background the Therapeutic Development Learning Community team is planning to host a series of “What Does it Cost?” webinars in 2026, bringing in experts to open up the conversation. The input from the questionnaire will assist in the design of the series. The survey will close on Friday, January 9th.

You can access the survey here: https://www.surveymonkey.com/r/L9V9QKW

Thank you for your participation!

Therapeutic Development Community Co-Chairs

• Maaike Everts, PhD, Executive Director, TRxA – the Translational Therapeutics Accelerator Program Critical Path Institute
• Mary O’Reilly, PhD, VP Bioscience Research, Flinn Foundation
• Kaitlin Davis, PhD, Director of Translational Science, Additional Ventures

[Christine Lagana Riordan]

REMINDER: Last chance to take the Therapeutic Development Learning Community Survey!! Survey closes January 9th!

The purpose of the survey is to gather information on the level of engagement and interest that members have in the development of new therapeutics. This is a complex area and as many of us do not have a therapeutics development background the Therapeutic Development Learning Community team is planning to host a series of “What Does it Cost?” webinars in 2026, bringing in experts to open up the conversation. The input from the questionnaire will assist in the design of the series. The survey will close on Friday, January 9th.

You can access the survey here: https://www.surveymonkey.com/r/L9V9QKW

Thank you for your participation!

Therapeutic Development Community Co-Chairs

• Maaike Everts, PhD, Executive Director, TRxA – the Translational Therapeutics Accelerator Program Critical Path Institute
• Mary O’Reilly, PhD, VP Bioscience Research, Flinn Foundation
• Kaitlin Davis, PhD, Director of Translational Science, Additional Ventures

[Author]

Posts